62 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
Condition: HIV/AIDS and Infections
Intervention: Biological: Hepatitis B vaccine
22 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
23 Recruiting The Safety and Immunogenicity of a Potential HIV Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 mixed with GLA-AF
24 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
25 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Intervention: Biological: Gardasil
26 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
27 Recruiting Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
Condition: HIV
Interventions: Biological: rcAd26.MOS1.HIV-Env 1x10^8 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^9 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^10 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^11 vp
28 Unknown  Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
Conditions: Tuberculosis;   HIV
Interventions: Biological: MVA85A;   Biological: Candin;   Biological: BCG Vaccine SSI
29 Not yet recruiting Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
30 Recruiting Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
Condition: HIV
Intervention: Biological: GTU®-multiHIV B clade
31 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
32 Recruiting A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
Conditions: Hepatitis C Infection;   HIV Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut;   Biological: ChAdV63.HIVconsv;   Biological: MVA.HIVconsv
33 Recruiting Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
34 Not yet recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
35 Recruiting Lipopeptide Immunisation With GTU-multiHIV Trial
Condition: HIV-1 Infection
Interventions: Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccines;   Biological: GTU-multHIV B vaccine and LIPO-5 vaccine
36 Unknown  Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Conditions: HIV Infections;   Hepatitis A;   Hepatitis B
Interventions: Biological: Twinrix;   Biological: interleukin-2
37 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
38 Not yet recruiting A T Cell-based HIV Vaccine
Condition: HIV
Interventions: Other: HIV positive subjects;   Other: Non-infected control subjects
39 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
40 Recruiting Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env;   Biological: DNA CON-S env;   Biological: DNA Mosaic env;   Biological: MVA-CMDR;   Biological: Placebo for DNA Nat-B env;   Biological: Placebo for DNA CON-S env;   Biological: Placebo for DNA Mosaic env;   Biological: Placebo for MVA-CMDR

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years